As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.

Lilly, which makes weight loss injections, unveils trial result showing Type 2 diabetes sufferers lost 8% of body weight ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity ... a recent study by the University of British Columbia linked GLP-1 (glucagon-like peptide-1) agonists — the class ...

But a new Canadian guideline, nearly five years in the making and the first Canadian update in nearly 20 years, recommends that, in addition to advice on diet ... at the University of Alberta ...

My dad, Michael Mosley, was an inspiration to millions of people worldwide – particularly those living with obesity or type 2 ...

Suddenly, GLP-1 drugs like Ozempic, Wegovy and Mounjaro are everywhere, promising rapid weight loss by blunting appetite and ...

Blockbuster weight loss meds like Ozempic and Wegovy are now linked to a rare eye disease that can lead to blindness.

But as a doctor I am very concerned that the mad scramble to get hold of semaglutide (brand names Ozempic and Wegovy ... on my father's successful Fast 800 diet, it offers a practical plan ...